ANN ARBOR, MI--(Marketwire - October 08, 2007) - Pipex Pharmaceuticals, Inc. (“Pipex” or the “Company”) (AMEX: PP), a specialty pharmaceutical company developing innovative late-stage oral drug candidates for the treatment of neurologic and fibrotic diseases, announced that it will ring today’s opening bell at the American Stock Exchange (“AMEX”).
